ArticleFrontiers in oncology2025

ZFAS1/STAT3 axis modulates imatinib resistance of chronic myeloid leukemia cells through glucose metabolism reprogramming.

Lan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.